Ruben van Boxtel
Utrecht University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ruben van Boxtel.
Cell | 2015
Sylvia F. Boj; Chang-Il Hwang; Lindsey A. Baker; Iok In Christine Chio; Dannielle D. Engle; Vincenzo Corbo; Myrthe Jager; Mariano Ponz-Sarvise; Hervé Tiriac; Mona S. Spector; Ana Gracanin; Tobiloba Oni; Kenneth H. Yu; Ruben van Boxtel; Meritxell Huch; Keith Rivera; John P. Wilson; Michael E. Feigin; Daniel Öhlund; Abram Handly-Santana; Christine M. Ardito-Abraham; Michael Ludwig; Ela Elyada; Brinda Alagesan; Giulia Biffi; Georgi Yordanov; Bethany Delcuze; Brianna Creighton; Kevin Wright; Youngkyu Park
Pancreatic cancer is one of the most lethal malignancies due to its late diagnosis and limited response to treatment. Tractable methods to identify and interrogate pathways involved in pancreatic tumorigenesis are urgently needed. We established organoid models from normal and neoplastic murine and human pancreas tissues. Pancreatic organoids can be rapidly generated from resected tumors and biopsies, survive cryopreservation, and exhibit ductal- and disease-stage-specific characteristics. Orthotopically transplanted neoplastic organoids recapitulate the full spectrum of tumor development by forming early-grade neoplasms that progress to locally invasive and metastatic carcinomas. Due to their ability to be genetically manipulated, organoids are a platform to probe genetic cooperation. Comprehensive transcriptional and proteomic analyses of murine pancreatic organoids revealed genes and pathways altered during disease progression. The confirmation of many of these protein changes in human tissues demonstrates that organoids are a facile model system to discover characteristics of this deadly malignancy.
Cell | 2015
Meritxell Huch; Helmuth Gehart; Ruben van Boxtel; Karien Hamer; Francis Blokzijl; Monique M.A. Verstegen; Ewa Ellis; Martien van Wenum; Sabine A. Fuchs; Joep de Ligt; Marc van de Wetering; Nobuo Sasaki; Susanne J. Boers; Hans Kemperman; Jeroen de Jonge; Jan N. M. IJzermans; Edward E. S. Nieuwenhuis; Ruurdtje Hoekstra; Stephen C. Strom; Robert G. Vries; Luc J. W. van der Laan; Edwin Cuppen; Hans Clevers
Summary Despite the enormous replication potential of the human liver, there are currently no culture systems available that sustain hepatocyte replication and/or function in vitro. We have shown previously that single mouse Lgr5+ liver stem cells can be expanded as epithelial organoids in vitro and can be differentiated into functional hepatocytes in vitro and in vivo. We now describe conditions allowing long-term expansion of adult bile duct-derived bipotent progenitor cells from human liver. The expanded cells are highly stable at the chromosome and structural level, while single base changes occur at very low rates. The cells can readily be converted into functional hepatocytes in vitro and upon transplantation in vivo. Organoids from α1-antitrypsin deficiency and Alagille syndrome patients mirror the in vivo pathology. Clonal long-term expansion of primary adult liver stem cells opens up experimental avenues for disease modeling, toxicology studies, regenerative medicine, and gene therapy.
Nature | 2015
Jarno Drost; Richard H. van Jaarsveld; Bas Ponsioen; Cheryl Zimberlin; Ruben van Boxtel; Arjan Buijs; Norman Sachs; René M. Overmeer; G. Johan A. Offerhaus; Harry Begthel; Jeroen Korving; Marc van de Wetering; Gerald Schwank; Meike Logtenberg; Edwin Cuppen; Hugo J. Snippert; Jan Paul Medema; Geert J. P. L. Kops; Hans Clevers
Crypt stem cells represent the cells of origin for intestinal neoplasia. Both mouse and human intestinal stem cells can be cultured in medium containing the stem-cell-niche factors WNT, R-spondin, epidermal growth factor (EGF) and noggin over long time periods as epithelial organoids that remain genetically and phenotypically stable. Here we utilize CRISPR/Cas9 technology for targeted gene modification of four of the most commonly mutated colorectal cancer genes (APC, P53 (also known as TP53), KRAS and SMAD4) in cultured human intestinal stem cells. Mutant organoids can be selected by removing individual growth factors from the culture medium. Quadruple mutants grow independently of all stem-cell-niche factors and tolerate the presence of the P53 stabilizer nutlin-3. Upon xenotransplantation into mice, quadruple mutants grow as tumours with features of invasive carcinoma. Finally, combined loss of APC and P53 is sufficient for the appearance of extensive aneuploidy, a hallmark of tumour progression.
Cell | 2014
Wouter R. Karthaus; Phillip J. Iaquinta; Jarno Drost; Ana Gracanin; Ruben van Boxtel; John Wongvipat; Catherine Dowling; Dong Gao; Harry Begthel; Norman Sachs; Robert G.J. Vries; Edwin Cuppen; Yu Chen; Charles L. Sawyers; Hans Clevers
The prostate gland consists of basal and luminal cells arranged as pseudostratified epithelium. In tissue recombination models, only basal cells reconstitute a complete prostate gland, yet murine lineage-tracing experiments show that luminal cells generate basal cells. It has remained challenging to address the molecular details of these transitions and whether they apply to humans, due to the lack of culture conditions that recapitulate prostate gland architecture. Here, we describe a 3D culture system that supports long-term expansion of primary mouse and human prostate organoids, composed of fully differentiated CK5+ basal and CK8+ luminal cells. Organoids are genetically stable, reconstitute prostate glands in recombination assays, and can be experimentally manipulated. Single human luminal and basal cells give rise to organoids, yet luminal-cell-derived organoids more closely resemble prostate glands. These data support a luminal multilineage progenitor cell model for prostate tissue and establish a robust, scalable system for mechanistic studies.
Nature Cell Biology | 2012
Kristan E. van der Vos; Pernilla Eliasson; Tassula Proikas-Cezanne; Stephin J. Vervoort; Ruben van Boxtel; Marrit Putker; Iris J. van Zutphen; Mario Mauthe; Sebastian Zellmer; Cornelieke Pals; Liesbeth P. Verhagen; Marian J. A. Groot Koerkamp; A. Koen Braat; Tobias B. Dansen; Frank C. P. Holstege; Rolf Gebhardt; Boudewijn M.T. Burgering; Paul J. Coffer
The PI(3)K–PKB–FOXO signalling network provides a major intracellular hub for the regulation of cell proliferation, survival and stress resistance. Here we report an unexpected role for FOXO transcription factors in regulating autophagy by modulating intracellular glutamine levels. To identify transcriptional targets of this network, we performed global transcriptional analyses after conditional activation of the key components PI(3)K, PKB/Akt, FOXO3 and FOXO4. Using this pathway approach, we identified glutamine synthetase as being transcriptionally regulated by PI(3)K–PKB–FOXO signalling. Conditional activation of FOXO also led to an increased level of glutamine production. FOXO activation resulted in mTOR inhibition by preventing the translocation of mTOR to lysosomal membranes in a glutamine-synthetase-dependent manner. This resulted in an increased level of autophagy as measured by LC3 lipidation, p62 degradation and fluorescent imaging of multiple autophagosomal markers. Inhibition of FOXO3-mediated autophagy increased the level of apoptosis, suggesting that the induction of autophagy by FOXO3-mediated glutamine synthetase expression is important for cellular survival. These findings reveal a growth-factor-responsive network that can directly modulate autophagy through the regulation of glutamine metabolism.
Nature | 2014
Sam Behjati; Meritxell Huch; Ruben van Boxtel; Wouter R. Karthaus; David C. Wedge; Asif U. Tamuri; Inigo Martincorena; Mia Petljak; Ludmil B. Alexandrov; Gunes Gundem; Patrick Tarpey; Sophie Roerink; Joyce Blokker; Mark Maddison; Laura Mudie; Ben Robinson; Serena Nik-Zainal; Peter J. Campbell; Nick Goldman; Marc van de Wetering; Edwin Cuppen; Hans Clevers; Michael R. Stratton
The somatic mutations present in the genome of a cell accumulate over the lifetime of a multicellular organism. These mutations can provide insights into the developmental lineage tree, the number of divisions that each cell has undergone and the mutational processes that have been operative. Here we describe whole genomes of clonal lines derived from multiple tissues of healthy mice. Using somatic base substitutions, we reconstructed the early cell divisions of each animal, demonstrating the contributions of embryonic cells to adult tissues. Differences were observed between tissues in the numbers and types of mutations accumulated by each cell, which likely reflect differences in the number of cell divisions they have undergone and varying contributions of different mutational processes. If somatic mutation rates are similar to those in mice, the results indicate that precise insights into development and mutagenesis of normal human cells will be possible.
Nature | 2016
Francis Blokzijl; Joep de Ligt; Myrthe Jager; Valentina Sasselli; Sophie Roerink; Nobuo Sasaki; Meritxell Huch; Sander Boymans; Ewart W. Kuijk; Pjotr Prins; Isaac J. Nijman; Inigo Martincorena; Michal Mokry; Caroline L. Wiegerinck; Sabine Middendorp; Toshiro Sato; Gerald Schwank; Edward E. S. Nieuwenhuis; Monique M.A. Verstegen; Luc J. W. van der Laan; Jeroen de Jonge; Jan N. M. IJzermans; Robert G. Vries; Marc van de Wetering; Michael R. Stratton; Hans Clevers; Edwin Cuppen; Ruben van Boxtel
The gradual accumulation of genetic mutations in human adult stem cells (ASCs) during life is associated with various age-related diseases, including cancer. Extreme variation in cancer risk across tissues was recently proposed to depend on the lifetime number of ASC divisions, owing to unavoidable random mutations that arise during DNA replication. However, the rates and patterns of mutations in normal ASCs remain unknown. Here we determine genome-wide mutation patterns in ASCs of the small intestine, colon and liver of human donors with ages ranging from 3 to 87 years by sequencing clonal organoid cultures derived from primary multipotent cells. Our results show that mutations accumulate steadily over time in all of the assessed tissue types, at a rate of approximately 40 novel mutations per year, despite the large variation in cancer incidence among these tissues. Liver ASCs, however, have different mutation spectra compared to those of the colon and small intestine. Mutational signature analysis reveals that this difference can be attributed to spontaneous deamination of methylated cytosine residues in the colon and small intestine, probably reflecting their high ASC division rate. In liver, a signature with an as-yet-unknown underlying mechanism is predominant. Mutation spectra of driver genes in cancer show high similarity to the tissue-specific ASC mutation spectra, suggesting that intrinsic mutational processes in ASCs can initiate tumorigenesis. Notably, the inter-individual variation in mutation rate and spectra are low, suggesting tissue-specific activity of common mutational processes throughout life.
Nature Methods | 2010
Isaac J. Nijman; Michal Mokry; Ruben van Boxtel; Pim W. Toonen; Ewart de Bruijn; Edwin Cuppen
Targeted genomic enrichment followed by next-generation DNA sequencing has dramatically increased efficiency of mutation-discovery efforts. We describe a protocol for genomic enrichment of pooled barcoded samples in a single assay that increases experimental flexibility and efficiency. We screened 770 genes (1.4 megabases) in thirty N-ethyl-N-nitrosourea (ENU)-mutagenized rats and identified known variants at >96% sensitivity as well as new mutations at a false positive rate < 1 in 8 megabases.
Obesity | 2012
Joram D. Mul; Ruben van Boxtel; Dylan J.M. Bergen; M A D Brans; Jan H. Brakkee; Pim W. Toonen; Keith M. Garner; Roger A.H. Adan; Edwin Cuppen
Obesity is caused by an imbalance between energy intake and expenditure and has become a major health‐care problem in western society. The central melanocortin system plays a crucial role in the regulation of feeding and energy expenditure, and functional loss of melanocortin receptor 4 (MC4R) is the most common genetic cause of human obesity. In this study, we present the first functional Mc4r knockout model in the rat, resulting from an N‐ethyl‐N‐nitrosourea mutagenesis–induced point mutation. In vitro observations revealed impaired membrane‐binding and subsequent nonfunctionality of the receptor, whereas in vivo observations showed that functional loss of MC4R increased body weight, food intake, white adipose mass, and changed substrate preference. In addition, intracerebroventricular (ICV) administration of Agouti‐Related Protein79–129 (AgRP79–129), an MC4R inverse agonist, or Melanotan‐II (MTII), an MC4R agonist, did affect feeding behavior in wild‐type rats but not in homozygous mutant rats, confirming complete loss of MC4R function in vivo. Finally, ICV administration of MTII induced excessive grooming behavior in wild‐type rats, whereas this effect was absent in homozygous mutant rats, indicating that MTII‐induced grooming behavior is exclusively regulated via MC4R pathways. Taken together, we expect that the MC4R rat model described here will be a valuable tool for studying monogenic obesity in humans. More specifically, the relative big size and increased cognitive capacity of rats as compared to mice will facilitate complex behavioral studies and detailed mechanistic studies regarding central function of MC4R, both of which ultimately may help to further understand the specific mechanisms that induce obesity during loss of MC4R function.
Molecular Systems Biology | 2014
Astrid Eijkelenboom; Michal Mokry; Elzo de Wit; Lydia M.M. Smits; Paulien E. Polderman; Miranda van Triest; Ruben van Boxtel; Almut Schulze; Wouter de Laat; Edwin Cuppen; Boudewijn M.T. Burgering
Forkhead box O (FOXO) transcription factors are key players in diverse cellular processes affecting tumorigenesis, stem cell maintenance and lifespan. To gain insight into the mechanisms of FOXO‐regulated target gene expression, we studied genome‐wide effects of FOXO3 activation. Profiling RNA polymerase II changes shows that FOXO3 regulates gene expression through transcription initiation. Correlative analysis of FOXO3 and RNA polymerase II ChIP‐seq profiles demonstrates FOXO3 to act as a transcriptional activator. Furthermore, this analysis reveals a significant part of FOXO3 gene regulation proceeds through enhancer regions. FOXO3 binds to pre‐existing enhancers and further activates these enhancers as shown by changes in histone acetylation and RNA polymerase II recruitment. In addition, FOXO3‐mediated enhancer activation correlates with regulation of adjacent genes and pre‐existence of chromatin loops between FOXO3 bound enhancers and target genes. Combined, our data elucidate how FOXOs regulate gene transcription and provide insight into mechanisms by which FOXOs can induce different gene expression programs depending on chromatin architecture.